CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,679,242 | +4.9% | 125,121 | +29.7% | 0.00% | 0.0% |
| Q2 2023 | $5,415,882 | -10.8% | 96,471 | -28.1% | 0.00% | 0.0% |
| Q1 2023 | $6,070,318 | +111.5% | 134,210 | +90.1% | 0.00% | +100.0% |
| Q4 2022 | $2,869,484 | +568.9% | 70,590 | +974.4% | 0.00% | – |
| Q3 2022 | $429,000 | -93.7% | 6,570 | -94.1% | 0.00% | -100.0% |
| Q2 2022 | $6,770,000 | -87.4% | 111,415 | -87.0% | 0.00% | -83.3% |
| Q1 2022 | $53,641,000 | -28.3% | 854,579 | -13.4% | 0.02% | -28.0% |
| Q4 2021 | $74,823,000 | -16.5% | 987,378 | +23.3% | 0.02% | -21.9% |
| Q3 2021 | $89,621,000 | -57.2% | 800,696 | -38.0% | 0.03% | -61.0% |
| Q2 2021 | $209,172,000 | +35.6% | 1,292,061 | +2.0% | 0.08% | +7.9% |
| Q1 2021 | $154,298,000 | +14.0% | 1,266,286 | +43.2% | 0.08% | +11.8% |
| Q4 2020 | $135,388,000 | +424.1% | 884,249 | +186.3% | 0.07% | +353.3% |
| Q3 2020 | $25,832,000 | +16.2% | 308,843 | +2.1% | 0.02% | -6.2% |
| Q2 2020 | $22,231,000 | +951.6% | 302,494 | +506.8% | 0.02% | +700.0% |
| Q1 2020 | $2,114,000 | +13.5% | 49,850 | +63.1% | 0.00% | -50.0% |
| Q4 2019 | $1,862,000 | +231.9% | 30,565 | +156.7% | 0.00% | +300.0% |
| Q2 2019 | $561,000 | +150.4% | 11,907 | +90.2% | 0.00% | – |
| Q1 2019 | $224,000 | -80.0% | 6,261 | -84.1% | 0.00% | -100.0% |
| Q4 2018 | $1,122,000 | -71.1% | 39,274 | -55.2% | 0.00% | -75.0% |
| Q3 2018 | $3,886,000 | +194.4% | 87,626 | +290.3% | 0.01% | +166.7% |
| Q2 2018 | $1,320,000 | +49.0% | 22,452 | +15.9% | 0.00% | +50.0% |
| Q1 2018 | $886,000 | – | 19,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |